Commercially Available Nebulized Medications Similar to Breztri
There are currently no commercially available nebulized formulations that replicate Breztri's triple therapy (ICS/LAMA/LABA) in a single solution. However, you can achieve equivalent triple therapy through separate nebulized medications used sequentially or in combination.
Individual Nebulized Components Available
To replicate Breztri's triple therapy via nebulization, you would need to use three separate nebulized agents 1:
1. Inhaled Corticosteroid (ICS) - Nebulized Options:
- Budesonide (Pulmicort Respules) - This is the most commonly available nebulized corticosteroid and matches one of Breztri's components 1
- Typical dosing: 0.25-1 mg twice daily via nebulizer
2. Long-Acting Muscarinic Antagonist (LAMA) - Nebulized Options:
- Ipratropium bromide (Atrovent) - Available for nebulization, though this is a short-acting anticholinergic rather than long-acting like glycopyrrolate 1
- Note: There is no commercially available nebulized long-acting anticholinergic equivalent to glycopyrrolate
3. Long-Acting Beta-2 Agonist (LABA) - Nebulized Options:
- Salbutamol/Albuterol (Ventolin) or Terbutaline (Bricanyl) - These are short-acting beta-agonists, not long-acting like formoterol 1
- Note: There is no commercially available nebulized long-acting beta-agonist equivalent to formoterol
Critical Limitations
The fundamental problem is that nebulized formulations lack true long-acting bronchodilators. While you can nebulize budesonide for the ICS component, both the anticholinergic (ipratropium) and beta-agonist (albuterol/salbutamol) available for nebulization are short-acting agents requiring dosing every 4-6 hours rather than twice daily 1.
Practical Clinical Approach
If a patient requires triple therapy but cannot use metered-dose or dry powder inhalers:
- Nebulize budesonide (Pulmicort Respules) twice daily for anti-inflammatory effect
- Nebulize ipratropium bromide 250-500 mcg every 6 hours for anticholinergic bronchodilation 1
- Nebulize albuterol/salbutamol 2.5-5 mg every 4-6 hours for beta-agonist bronchodilation 1
This regimen requires 4-6 nebulization sessions daily (compared to 2 puffs twice daily with Breztri), significantly impacting adherence and quality of life 2.
Important Caveats
- Nebulizers should only be used when hand-held inhalers are ineffective or when coordinated breathing is difficult 1
- Equipment must be cleaned after every use to prevent respiratory infections 1
- The lack of long-acting agents in nebulized form means this approach provides inferior convenience and potentially suboptimal disease control compared to Breztri
- Breztri itself is only available as a metered-dose inhaler (Aerosphere delivery system), not as a nebulized solution 2